Lisa M Ebert

15PUBLICATIONS
41CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyAustralian literature (excl. Aboriginal and Torres Strait Islander literature)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 07, 2024
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses.

Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang

|Jul 08, 2024
Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma.

Wenbo Yu, Nga Th Truong, Ruhi Polara

|Jun 27, 2024
Striking an alliance between T cells and macrophages for enhanced cancer immunotherapy.

Tessa Gargett, Lisa M Ebert

|May 16, 2024
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.

Tessa Gargett, Nga T H Truong, Bryan Gardam

|Feb 20, 2024
Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy.

Isabella A Revesz, Paul Joyce, Lisa M Ebert

|Oct 25, 2023
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma.

Brett W Stringer, Manam Inushi De Silva, Zarina Greenberg

Pageof 3

Frequent Collaborators

3 joint publications

Michael P Brown

2 joint publications

Guillermo A Gomez

2 joint publications

Erica C F Yeo

2 joint publications

Santosh Poonoose